ABBA Therapeutics' Incubator/Accelerator Round

ABBA Therapeutics raised a round of funding on September 18, 2017. Investors include BaseLaunch.

ABBA Therapeutics develops therapeutic antibodies against novel targets for cancer immunotherapy.…

Articles about ABBA Therapeutics' Incubator/Accelerator Round: